UMMS Affiliation

Commonwealth Medicine, Clinical Pharmacy Services

Publication Date

2016-12-08

Document Type

Technical Report

Disciplines

Health Economics | Health Law and Policy | Health Policy | Health Services Administration | Health Services Research | Pharmacy Administration, Policy and Regulation

Abstract

Pipeline Trends is produced by UMass Medical School’s Clinical Pharmacy Services division and is distributed at least once a year. This edition provides a comprehensive overview of:

  • Promising New Agents: Abaloparatide, Cannabidiol, Dupilumab, and others
  • Projected Generic Entry: Strattera®, Tamiflu®, Truvada®, Zetia®, and others
  • Investigational Indications: Cabozantinib and Tofacitinib
  • FDA Updates
  • Industry Trends

Keywords

pharmacy, pharmaceuticals, drugs, therapeutic agents, drug therapy

Rights and Permissions

© University of Massachusetts Medical School 2016

Journal/Book/Conference Title

Pipeline Trends

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.